相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
Peter Kalev et al.
CANCER CELL (2021)
PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion
Vicente Peg et al.
FUTURE ONCOLOGY (2021)
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial
Jeffrey A. How et al.
INVESTIGATIONAL NEW DRUGS (2021)
Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease
Jessica A. Pilsworth et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary
Arnaud Paula et al.
MODERN PATHOLOGY (2020)
Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup
Joline Roze et al.
CANCERS (2020)
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia Leon-Castillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing
Maria Alexiadis et al.
MOLECULAR CANCER RESEARCH (2019)
TERT promoter mutation in adult granulosa cell tumor of the ovary
Jessica A. Pilsworth et al.
MODERN PATHOLOGY (2018)
KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary
R. Tyler Hillman et al.
NATURE COMMUNICATIONS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman et al.
LANCET (2017)
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher et al.
LANCET ONCOLOGY (2017)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Yi Kan Wang et al.
NATURE GENETICS (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
Jie He et al.
BLOOD (2016)
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study*
Elizabeth R. Burton et al.
GYNECOLOGIC ONCOLOGY (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
Gregory V. Kryukov et al.
SCIENCE (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors
Jubilee Brown et al.
CANCER (2014)
Hormone therapy in ovarian granulosa cell tumors: A systematic review
Hannah S. van Meurs et al.
GYNECOLOGIC ONCOLOGY (2014)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors
Hsu-Dong Sun et al.
GYNECOLOGIC ONCOLOGY (2012)
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson et al.
NATURE MEDICINE (2012)
Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study
In Ho Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2011)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors
J Brown et al.
GYNECOLOGIC ONCOLOGY (2005)
Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development
M Uda et al.
HUMAN MOLECULAR GENETICS (2004)
分享论文
